Navigation Links
Biopsy Device Market (By Country Wise and Product Segment) and Biopsy Procedure Volume Forecast To 2020 - Global Analysis
Date:4/12/2017

NEW YORK, April 12, 2017 /PRNewswire/ -- Biopsy devices are gaining traction within the industry as a viable alternative to traditional screening methods for cancer. The biopsy device market will experience considerable growth over the forecast period, driven by an increasing number of biopsy procedures. An increasing prevalence of cancer, geriatric population and increasing demand for minimally invasive procedures are expected to drive market growth during the forecast period. Growing patient awareness levels and the advancement in biopsy techniques are also expected to fuel future growth of the market.

By Product Segment - Biopsy Device Market Analysis: The market for biopsy guidance systems held the largest share in 2015 and is expected to continue to lead the market throughout the forecasting period. The biopsy guidance systems is followed by the needle based biopsy guns segment. Vacuum-assisted biopsy devices represent the fastest growing segment, and increased Medicare reimbursement given for such procedures is expected to help fuel demand. The market for biopsy needles is expected to remain relatively constant throughout the forecasting period. Forceps and Other devices are expected to account for lesser shares as compared to the other segments, due to their specific applications and also risks associated with their use.

By Country Biopsy Device Market Analysis: United States is the largest regional market for biopsy devices. United States is likely to remain the leading country in biopsy device market throughout the forecasting period. China is the second leading market for biopsy devices being followed by India. Brazil is the fourth most popular country for biopsy devices accounting for XXXX% market share in 2015. Among the European countries, Germany is the leading market for Biopsy device accounting for XXXX% market share in 2015.

By Region Biopsy Procedure Volume Analysis: In the Global biopsy procedure volume, Asia accounted for the largest share in 2015. It is predicted that Asia will remain at the dominating position in Global biopsy procedures throughout the forecasting period. United States holds the second largest volume share in 2015. Europe is the third leading region for biopsy procedure being followed by Brazil.

Company Wise Biopsy Products Analysis: In this segment company wise detailed analysis of biopsy products have been covered along with features and advantages of biopsy products. The report also studies major mergers and acquisition/deals in the biopsy market landscape.

This is the 2nd edition report on Biopsy Market by iGATE RESEARCH. The report titled "Biopsy Device Market (By Country Wise and Product Segment) and Biopsy Procedure Volume Forecast To 2020 - Global Analysis" is a 233 Page report with 61 Figures and 9 Tables. This report studies in detail the Global Biopsy Device Market, Biopsy Procedure Volume, Products Segment Market for Biopsy Devices, Country Wise Biopsy Device Market and Biopsy Procedure Volume, Companies Biopsy Products Analysis, Major deals in Biopsy Device Market, Driving Factors and Challenges for Biopsy Device Market.

Biopsy Device Market and Forecast - 5 Biopsy Device Segments Covered

1. Needle-based Biopsy Guns (2012 - 2020)
2. Biopsy Needles (2012 - 2020)
3. Biopsy Forceps (2012 - 2020)
4. Biopsy Guidance Systems (2012 - 2020)
5. Others (2012 - 2020)

Biopsy Device Market and Forecast - 11 Countries Covered

1. United States (2012 - 2020)
2. Brazil (2012 - 2020)
3. UK (2012 - 2020)
4. France (2012 - 2020)
5. Germany (2012 - 2020)
6. Italy (2012 - 2020)
7. Spain (2012 - 2020)
8. Japan (2012 - 2020)
9. India (2012 - 2020)
10. China (2012 - 2020)
11. Rest of the World (2012 - 2020)

Companies Biopsy Products Analysis - 11 Companies Covered

1. Argon Medical Devices
2. Boston Scientific
3. Carefusion Corporation (Acquired By Becton, Dickinson and Company)
4. C. R. BARD, Inc
5. Cook Medical
6. Devicor Medical Products Inc.
7. Gallini Medical Devices
8. Hologic, Inc
9. INRAD, Inc
10. Intact Medical Corporation
11. TSK Laboratory

Biopsy Procedure Volume and Forecast - 4 Regions Covered

1. United States (2012 - 2020)
2. Asia (2012 - 2020)
3. Europe (2012 - 2020)
4. Brazil (2012 - 2020)

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases

Read the full report: http://www.reportlinker.com/p04603838-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biopsy-device-market-by-country-wise-and-product-segment-and-biopsy-procedure-volume-forecast-to-2020---global-analysis-300439048.html


'/>"/>
SOURCE Reportlinker
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. QIAGEN Expands Liquid Biopsy Pipeline with AR-V7 Test in Prostate Cancer
2. Indivumed Founder and CEO Recognized for Contribution to Liquid Biopsy Innovation
3. QIAGEN Joins CANCER-ID Consortium for Liquid Biopsy Workflows
4. Biocept and Catalyst Pharmaceuticals Collaborate to Provide Liquid Biopsy Testing for Small Cell Lung Cancer to Patients with Lambert Eaton Myasthenic Syndrome (LEMS)
5. MD Anderson and Guardant Health announce partnership to make comprehensive liquid biopsy part of oncology standard of care
6. Microfabrica Partners with US Endoscopy to Produce Worlds First Submillimeter Biopsy Forceps
7. Global Liquid Biopsy Market Forecast 2017-2027
8. Guardant Health to create a new 500-plus-gene liquid biopsy panel with several leading pharmaceutical companies to accelerate clinical trials and drug development
9. MDNA Selects Phi Life Sciences as its First US Distribution Partner for its New Liquid Biopsy Test for Prostate Cancer
10. DILON Diagnostics and GE Healthcare announce the FDA clearance of the Discovery NM 750b biopsy accessory
11. QIAGEN Launches Liquid Biopsy Workflow for GeneReader NGS System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), ... solutions, today announced that its MyDario product is expected to appear on ... for when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
Breaking Medicine News(10 mins):